The Claim
Elevated circulating levels of COL4A1 and ANP derived from epicardial fat are associated with an increased risk of all-cause mortality in patients with cardiovascular disease, while elevated circulating levels of CA125 and ICAM-1 are associated with an increased risk of major adverse cardiovascular events.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of specific proteins—COL4A1 and ANP from fat around the heart, and CA125 and ICAM-1 in the blood—are linked to a higher chance of death or serious heart problems in people with cardiovascular disease.
See the scientific wording
Elevated circulating levels of COL4A1 and ANP released from epicardial fat are associated with increased risk of all-cause mortality in patients with cardiovascular disease, while CA125 and ICAM-1 are associated with major adverse cardiovascular events.
Fat around the heart releases proteins that stiffen blood vessels and trigger inflammation, causing heart damage and increasing the chance of death. Other proteins from the same fat cause acute heart problems like heart attacks by making blood vessels leaky and attracting harmful immune cells.
What the research says
1 studyThe study found that heart fat releases certain proteins—COL4A1 and ANP—that are linked to a higher risk of dying from any cause, and others—CA125 and ICAM-1—that are linked to serious heart problems like heart attacks. This matches exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.